Lonza’s Bioscience division, consisting of its Cell Therapy, Rapid Testing Systems, Media, and Cell Discovery and Molecular Biology businesses, reported CHF 82 million ($66.9 million) in sales and EBIT of CHF 12 million ($9.8 million) for the first half of 2007. Media, and Cell Discovery and Molecular Biology sales were lower than expected. CellSystems Biotechnologies Vertrieb GmbH will exclusively distribute International Stem Cell’s Lifeline brand of living human cell and cell culture research products in Europe. Cisbio gained exclusive rights to Lumiphore’s Lumi4 technology for its R&D initiatives in TR-FRET based assays for drug discovery. Ventana Medical Systems acquired Spring BioScience, a supplier of monoclonal antibodies and other reagents, in September for $28.9 million in cash and up to $11.7 million over two years based on milestones. ABR-Affinity BioReagents will distribute in the US products from Genesis Biotech, a provider of antibodies focused on gene function and discovery, and Good Biotech, a manufacturer of antibodies for disease research. Sigma-Aldrich partnered with Ingenuity Systems to create new search capabilities for its website. Sigma-Aldrich named Patrick M. Sullivan vice president of R&D for its Research Biotech unit effective October 1. He was most recently employed by Pfizer. Fluorotechnics appointed three new sales and marketing partners: Biomed Diagnostics for Singapore, Malaysia and Thailand; Chayon Laboratories for South Korea; and Dakewe Biotech for China. Applied Biosystems signed an exclusive license and collaboration agreement for Olink Bioscience’s proximity ligation assay technology.